WASHINGTON, DC — Jay Bhattacharya’s vow to welcome scientific dissent is under pressure just months into his tenure as director of the National Institutes of Health. At his Senate confirmation hearing ...
WASHINGTON — When President Donald Trump's administration announced it would repurpose an old, generic drug as a new treatment for autism, it came as a surprise to many experts — including the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback